• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » WIRB-Copernicus Group acquires New England IRB

WIRB-Copernicus Group acquires New England IRB

September 10, 2014
CenterWatch Staff

New England IRB (NEIRB) will become part of the growing group of recently acquired IRBs by WIRB-Copernicus Group (WCG), the world’s largest provider of regulatory and ethical review services for clinical research.

The acquisition expands WCG’s presence in New England clinical research and further increases NEIRB’s expertise in all phases of drug, medical device and behavioral research. The purchase follows WCG’s acquisitions in June of Midlands IRB of Kansas City, Mo., and San Diego-based Aspire IRB.

Financial terms of all three deals were not disclosed.

“With NEIRB we get a leadership IRB with an outstanding reputation and regional presence and an east coast leader in the hot spot of the biotech industry—the Boston area,” said Donald A. Deieso, Ph.D., WCG chairman and CEO.

He said NEIRB, like WCG’s other acquisitions, will remain independent, keeping its name and leadership intact, but it will be able to accelerate growth with access to WCG’s information technology and capital resources, training, business and science expertise and expanded marketing and sales.

For James Saunders, NEIRB president, becoming part of WCG will enable the 26-year-old IRB to provide clients with greater access to technologies and processes to make clinical research more efficient.

For more details, read the upcoming issue of CWWeekly on Monday, Sept. 15.

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing